Updated Jul 16, 2026
Miller Andrew Craig has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Andrew Craig Miller is associated with Kyverna Therapeutics, Inc., a company focused on developing innovative therapies for autoimmune diseases. Specific details about his role or contributions to the company are not widely documented.
| Role | Director |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-04 | KYTX | Kyverna Therapeutics, Inc. | A — Grant or award | 11.0K | $0.00 |
Andrew Craig Miller is associated with Kyverna Therapeutics, Inc., a company focused on developing innovative therapies for autoimmune diseases. Specific details about his role or contributions to the company are not widely documented.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Miller Andrew Craig profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.